T 1870/22 (SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLIC ACID/Novo Nordisk A/S) of 29.11.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T187022.20241129
- Date of decision
- 29 November 2024
- Case number
- T 1870/22
- Online on
- 21 February 2025
- Petition for review of
- -
- Application number
- 17204363.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
- Applicant name
- Novo Nordisk A/S
- Opponent name
- Teva Pharmaceutical Industries Ltd
Hexal AG
Galenicum Health S.L.U.
Generics (U.K.) Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 76(1)European Patent Convention R 80
- Keywords
- Amendment occasioned by ground for opposition - (yes)
Divisional application - extension beyond the content of the earlier application as filed (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division for further prosecution.